Jazz Pharmaceuticals: Q1 Earnings Insights

Jazz Pharmaceuticals JAZZ reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:05 PM.

Here's what investors need to know about the announcement.

Earnings

Jazz Pharmaceuticals missed estimated earnings by 2.61%, reporting an EPS of $3.73 versus an estimate of $3.83.

Revenue was up $206.14 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.58 which was followed by a 12.05% increase in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance:

To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.